Drug Profile
Research programme: VLA-1 inhibitors - Array BioPharma/ICOS Corporation
Alternative Names: A-328282.0; VLA-1 antagonists - Array/ICOSLatest Information Update: 02 Aug 2019
Price :
$50
*
At a glance
- Originator Array BioPharma; ICOS Corporation
- Class
- Mechanism of Action Integrin alpha1beta1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Inflammation
Most Recent Events
- 30 Jul 2019 Array Biopharma has been acquired by Pfizer
- 23 Mar 2009 Discontinued for Inflammation in USA (unspecified route)
- 16 Apr 2007 Early research in Inflammation in USA (unspecified route)